On The Line: Beware angry Quebec voters, and, rogue AIs
About this episode
The episode discusses the intersection of politics, technology, and trust, featuring insights on Quebec voters and cancer immunotherapy advancements.
In this episode of On The Line, host Matt Gurney is joined by two guests for conversations about politics, technology, and trust. This episode of On The Line is brought to you by BioCanRX, a federally funded, not-for-profit Canadian research network that specializes in bringing Canadian cancer immunotherapy research from the lab all the way to patients in clinical trials in Canada. Can science help your immune system detect and destroy cancer? Immunotherapy is about assisting your immune system in identifying unhealthy cells –– especially cancer –– that have found a way to evade detection. One way researchers are doing this is through something called CAR T. They draw your blood, isolate one type of your immune cells –– T-Cells –– and use a virus to inject genetic instructions that cause them to grow new receptors designed specifically to bind with your particular cancer. When those cells are re-infused into your body, they hopefully will be able to find and destroy your cancer. The results are promising. In one of the 16 trials BioCanRx funds based on Canadian technology, CLIC-01, the median number of months remaining for patients with late-stage leukemia and lymphoma tripled…
Sponsors
BioCanRX
More episodes of The Line Podcast
- The Line Podcast: Canada and America, a (gross) love story
- The Line Podcast: Canadians secretly love Mark Carney BECAUSE he yells
- On The Line: What Canadian digital sovereignty?
- The Line Podcast: Carney is winning the vibes war
- On The Line: When Trump is gone, will we still want a bigger military?
- The Line Podcast: Alberta wakes up, chooses chaos, drags 35 million Canadians along
Explore listener stats, chart rankings, contacts and more on the The Line Podcast podcast page.